Engineering Liver Therapies for the Future
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Treatment of liver disease has been greatly improved by the advent and evolution of liver transplantation. However, as demand for donor organs continues to increase beyond their availability, the need for alternative liver therapies is clear. Several approaches including extracorporeal devices, cell transplantation, and tissue-engineered constructs have been proposed as potential adjuncts or even replacements for transplantation. Simultaneously, experience from the liver biology community have provided valuable insight into tissue morphogenesis and in vitro stabilization of the hepatocyte phenotype. The next generation of cellular therapies must therefore consider incorporating cell sources and cellular microenvironments that provide both a large population of cells and strategies to maintain liver-specific functions over extended time frames. As cell-based therapies evolve, their success will require contribution from many diverse disciplines including regenerative medicine, developmental biology, and transplant medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liver from bone marrow in humans
Theise, N. D., Nimmakayalu, M., Gardner, R., Illei, P. B., Morgan, G., Teperman, L., Henegariu, O., & Krause, D. S. (2000) · Hepatology · doi:10.1053/jhep.2000.9124 · Cited by 1,210
Bhatia, S. N., Balis, U. J., Yarmush, M. L., & Toner, M. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.14.1883 · Cited by 890
Self-citationInitiation of Mammalian Liver Development from Endoderm by Fibroblast Growth Factors
Jung, J., Zheng, M., Goldfarb, M., & Zaret, K. S. (1999) · Science · doi:10.1126/science.284.5422.1998 · Cited by 721
Inhibition of Experimental Liver Cirrhosis in Mice by Telomerase Gene Delivery
Rudolph, K. L., Chang, S., Millard, M., Schreiber-Agus, N., & DePinho, R. A. (2000) · Science · doi:10.1126/science.287.5456.1253 · Cited by 424
Suzuki, A., Zheng, Y.-W., Kaneko, S., Onodera, M., Fukao, K., Nakauchi, H., & Taniguchi, H. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200108066 · Cited by 356 · cited 1×
“48 In addition, it appears that hematopoietic stem cells can generate hepatocytes directly as well as through an oval cell intermediate, depending on the mode of injury and the model system.”
Microencapsulated human hepatoma (HepG2) cells: In vitro growth and protein release
Uludag, H., & Sefton, M. V. (1993) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820271002 · Cited by 74
Cited by
Tissue Engineering and Regenerative Medicine: History, Progress, and Challenges
Berthiaume, F., Maguire, T. J., & Yarmush, M. L. (2011) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-061010-114257 · Cited by 734
Kharaziha, P., Hellström, P. M., Noorinayer, B., Farzaneh, F., Aghajani, K., Jafari, F., Telkabadi, M., Atashi, A., Honardoost, M., Zali, M. R., et al. (2009) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32832a1f6c · Cited by 492
Advanced biomaterials for skeletal tissue regeneration: Instructive and smart functions
Barrère, F., Mahmood, T. A., de Groot, K., & van Blitterswijk, C. A. (2008) · Materials Science and Engineering: R: Reports · doi:10.1016/j.mser.2007.12.001 · Cited by 303
Ho, C.-T., Lin, R.-Z., Chang, W.-Y., Chang, H.-Y., & Liu, C.-H. (2006) · Lab on a Chip · doi:10.1039/b602036d · Cited by 283
Maintenance of Human Hepatocyte Function In Vitro by Liver-Derived Extracellular Matrix Gels
Sellaro, T. L., Ranade, A., Faulk, D. M., McCabe, G. P., Dorko, K., Badylak, S. F., & Strom, S. C. (2010) · Tissue Engineering Part A · doi:10.1089/ten.tea.2008.0587 · Cited by 276
Metadata
- Authors
- Allen, J. W., & Bhatia, S. N.
- Venue
- Tissue Engineering
- Publisher
- SAGE Publications
- Published
- 2002-10
- Volume
- 8
- Issue
- 5
- Pages
- 725-737
- ISSN
- 1076-3279 (ISSN-L)
- 1557-8690
- OpenAlex
- W2176690355
- Cited by
- 132
- References
- 6
- FWCI
- 5.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Engineering Liver Therapies for the Future. https://app.cochat.ai/papers/10.1089/10763270260424097
- The paper
- Allen, J. W., & Bhatia, S. N. (2002). Engineering Liver Therapies for the Future. Tissue Engineering. https://doi.org/10.1089/10763270260424097
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.